Home > Product > Recombinant Protein
Recombinant Protein
Recombinant proteins are obtained by the use of recombinant DNA or recombinant RNA. The expression platforms of recombinant protein mainly include five expression systems: escherichia coli, bacillus subtilis, yeast, mammalian cells and insect baculovirus cells.
Alias:
Spinesin; TMPRSS 5; TMPRSS-5; TMPRSS5; TMPS5_HUMAN; Transmembrane protease serine 5; Transmembrane protease, serine 5 (spinesin); Transmembrane protease, serine 5; MGC141886; MGC148044; OTTHUMP00000238209; OTTHUMP00000238210; OTTHUMP00000238211; OTTHUMP00
Species Reactivity:
(predicted: Human,Mouse,Rat,Dog,Pig,Cow,Horse,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
F4/80; Cell surface glycoprotein EMR1; Cell surface glycoprotein F4/80; DD7A5 7; Egf like module containing mucin like hormone receptor like 1; Egf like module containing mucin like hormone receptor like sequence 1; EGF like module receptor 1; EGF TM7; E
Species Reactivity:
(predicted: Human,Mouse,Rat,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
MGC87379; Myelin associated oligodendrocyte basic protein; MOBP_HUMAN.
Species Reactivity:
(predicted: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Sheep,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
CK-19; CK 19; 40 kDa keratin intermediate filament; CK 19; Cytokeratin19; ck19; Cytokeratin 19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; Cytokeratin 17; Cytokeratin
Species Reactivity:
(predicted: Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
type I cytoskeletal 10; BCIE; BIE; CK 10; CK-10; ck10; Cytokeratin 10; Cytokeratin-10; Cytokeratin10; EHK; k10; K1C10_HUMAN; Keratin 10; Keratin; Keratin type i cytoskeletal 10; Keratin type I cytoskeletal 59 kDa; Keratin-10; Keratin10; kpp; Krt 10; KRT10
Species Reactivity:
(predicted: Human,Mouse,Rat,Pig,Cow,Horse,Rabbit,Sheep,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
Cytokeratin 42; K1C42_MOUSE; Keratin, type I cytoskeletal 42; Cytokeratin-42; CK-42; Keratin-17n; Keratin-42; K42; Type I keratin Ka22; Keratin, type I cytoskeletal 14; KRT14.
Species Reactivity:
(predicted: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
C13orf2; BTB/POZ domain-containing protein KCTD12; C13orf2; KCD12_HUMAN; KCTD12; KIAA1778; PFET1; Pfetin; potassium channel tetramerisation domain containing 12 USA; Predominantly fetal expressed T1 domain.
Species Reactivity:
(predicted: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
Breast cancer metastasis suppressor 1; Breast cancer metastasis-suppressor 1; BRMS-1; BRMS1_HUMAN; DKFZp564A063; MGC95128; AV003220; AW554636.
Species Reactivity:
Human,Mouse,Rat,(predicted: Dog,Pig,Horse,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
C/EBP gamma; CCAAT/enhancer binding protein (C/EBP) gamma; CCAAT/enhancer binding protein gamma; CEBPG; GPE1BP; IG/EBP 1; IG/EBP1; CEBPG_HUMAN.
Species Reactivity:
(predicted: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep,)
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Alias:
C9a, C9 deficiency; C9a; C9 deficiency with dermatomyositis; CO9_HUMAN; Complement component 9; Complement component 9 deficiency; Complement component C9a; Complement component C9a; C9.
Species Reactivity:
Human,
Clonality:
Polyclonal
Applications:
ICC=1:50-200IF=1:50-200not yet tested in other applications.optimal dilutions/concentrations should be determined by the end user.
Copyright © 2007-2018 Sunlong Medical All Rights Reserved.